# Next Step Evidence Summary

## Executive Summary
This report synthesizes the structural evidence review to refine the Biological Countercurvature hypothesis. It highlights areas where the evidence has solidified, clarifies points of weakness or over-interpretation, and prioritizes the immediate experimental next steps.

### What is Stronger Now Than Baseline
* **Rigorous Separation of 'Tension Rods'**: By applying an explicit confidence threshold (pLDDT >= 70) to the anisotropy rankings, we have definitively identified proteins like **PIEZO2** (Anisotropy: 4.44) and **ADGRG6** (Anisotropy: 3.06) as robustly extended, high-confidence structures. This moves the "Tension Rod" concept from a general theory to a specific, measurable structural class.
* **Refined Definition of LBX1's Structure**: We have structurally confirmed that LBX1 is **not** a rigid "tension rod". It consistently exhibits intermediate anisotropy (2.27), low confidence (66.87), and high PAE blockiness (7.35). This strongly supports a "beads-on-a-string" architecture rather than a load-bearing one, shifting the focus towards its potential as a tension-gated or nuclear stiffness-sensitive node.

### What Remains Weak (Or Falsified as Evidence)
* **High-Anisotropy Artifacts**: Extreme anisotropic candidates like **POC5** (24.69) and **GHR** (5.13) suffer from low pLDDT scores (< 70). Without orthogonal validation, their extended geometries may be artifacts of unstructured flexible linkers being artificially stretched during AlphaFold modeling. They currently represent weak structural evidence.
* **Temporal Over-Interpretation**: The evidence freshness audit revealed that the core genes' metrics (LBX1, POC5, LMNA, GHR) have remained **completely static** across the January-February run window. Any narratives in the cluster notes implying structural evolution, newly emerging states, or longitudinal changes during this period are falsified and represent analytical artifacts.
* **LBX1's Causal Mechanism**: While the "blocky" nature of LBX1 is confirmed by metrics, the specific causal leap that this blockiness makes it uniquely dependent on nuclear tension (unlike RUNX3) remains a purely speculative narrative lacking direct biological measurement.

### Top 3 Highest-Leverage Next Experiments
1. **LBX1 Nuclear Tension Perturbation Assay**: Express full-length GFP-LBX1 vs GFP-RUNX3 in myoblasts. Perturb nuclear stiffness via Latrunculin B or Lamin A/C knockdown, and measure nuclear localization and transcriptional activity. This directly tests the speculative narrative surrounding LBX1's "blockiness" and tension sensitivity.
2. **Orthogonal Validation of High-Anisotropy Outliers**: Perform biophysical stiffness assays or structural proteomics (e.g., cross-linking mass spectrometry) on low-confidence, high-anisotropy candidates like POC5 and GHR. This is necessary to confirm whether their extreme elongation is real or an AlphaFold hallucination.
3. **Ensemble/Disorder-Aware Modeling of LBX1**: Run advanced conformational sampling or multimer-aware structural predictions for LBX1. This will determine if its high blockiness and intermediate anisotropy are robust features or merely consequences of modeling a multi-domain protein in isolation.
